Lijian Yang

Lijian Yang

Auto-generated profile, based on publicly available information

Lijian Yang

Central China Normal University

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2013 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
LSLi Shi
Li Shi
SCShaohua Chen
Shaohua Chen
LYLijian Yang
Lijian Yang
YLYangqiu Li
Yangqiu Li
T-cell activation and dysfunction relies on direct and modulated receptors. Based on their functional outcome, co-signaling molecules can be divided as co-stimulators and co-inhibitors, which positively and negatively control the priming, growth, differentiation and functional maturation of a T-cell response. We are beginning to understand the power of co-inhibitors in the context of lymphocyte homeostasis and the pathogenesis of leukemia, which involves several newly described co-inhibitory pathways, including the programmed death-1 (PD-1) and PD-1 ligand (PD-L1) pathway. The aim of this review is to summarize the PD-1 and PD-L1 biological functions and their alterative expression in hematological malignancies. The role of PD-1 and PD-L1 in T-cell immune suppression and the potential for immunotherapy via blocking PD-1 and PD-L1 in hematological malignancies are also reviewed.

23 September 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
CZChengwu Zeng
Chengwu Zeng
YXYan Xu
Yan Xu
LXLing Xu
Ling Xu
XYXibao Yu
Xibao Yu
JCJingjing Cheng
Jingjing Cheng
YLYangqiu Li
Yangqiu Li
Acute promyelocytic leukemia (APL) is characterized by the reciprocal translocation t(15;17), which fuses PML with retinoic acid receptor alpha (RARα). Although PML-RARα is crucially important for pathogenesis and responsiveness to treatment, the molecular and cellular mechanisms by which PML-RARα exerts its oncogenic potential have not been fully elucidated. Recent reports have suggested that long non-coding RNAs (lncRNAs) contribute to the precise control of gene expression and are involved in human diseases. Little is known about the role of lncRNA in APL. We analyzed NEAT1 expression in APL samples and cell lines by real-time quantitative reverse transcription-PCR (qRT-PCR). The expression of PML-RARα was measured by Western blot. Cell differentiation was assessed by measuring the surface CD11b antigen expression by flow cytometry analysis. We found that nuclear enriched abundant transcript 1 (NEAT1), a lncRNA essential for the formation of nuclear body paraspeckles, is significantly repressed in de novo APL samples compared with those of healthy donors. We further provide evidence that NEAT1 expression was repressed by PML-RARα. Furthermore, significant NEAT1 upregulation was observed during all-trans retinoic acid (ATRA)-induced NB4 cell differentiation. Finally, we demonstrate the importance of NEAT1 in myeloid differentiation. We show that reduction of NEAT1 by small interfering RNA (siRNA) blocks ATRA-induced differentiation. Our results indicate that reduced expression of the nuclear long noncoding RNA NEAT1 may play a role in the myeloid differentiation of APL cells.

7 November 2017 in Nonlinear Dynamics
Verified
Journal Article
Closed access
PDF file
MGMengyan Ge
Mengyan Ge
YJYa Jia
Ya Jia
YXYing Xu
Ying Xu
LYLijian Yang
Lijian Yang

1 March 2018 in Neurocomputing
Verified
Journal Article
Closed access
YXYing Xu
Ying Xu
YJYa Jia
Ya Jia
MGMengyan Ge
Mengyan Ge
LLLulu Lu
Lulu Lu
LYLijian Yang
Lijian Yang
XZXuan Zhan
Xuan Zhan

19 October 2018 in Science China Technological Sciences
Verified
Journal Article
Closed access
PDF file
LLLuLu Lu
LuLu Lu
YJYa Jia
Ya Jia
YXYing Xu
Ying Xu
MGMengYan Ge
MengYan Ge
LYLiJian Yang
LiJian Yang
XZXuan Zhan
Xuan Zhan

11 November 2018 in Nonlinear Dynamics
Verified
Journal Article
Closed access
PDF file
LLLulu Lu
Lulu Lu
YJYa Jia
Ya Jia
JKJohn Billy Kirunda
John Billy Kirunda
YXYing Xu
Ying Xu
MGMengyan Ge
Mengyan Ge
LYLijian Yang
Lijian Yang